Vijay Kumar
Professor
Nuclear Medicine
University of Sydney
Australia
Biography
Dr.Vijay Kumar is a Clinical Professor USYD, Principal Radiopharmaceutical Scientist, Department of Nuclear Medicine, Westmead Hospital and The Children's Hospital.Worked at International Atomic Energy Agency, Vienna (2010), as Consultant Scientific Expert
Research Interest
Research Interest: Primarily involved in designing radiolabelled radiopharmaceuticals for evaluation in pre-clinical studies in an animal model and then using them in patient studies in a clinical setting. We have developed Ga-68 labelled PET-agents (Positron emitting isotopes) for imaging neuro-endocrine tumours, prostate cancer and bacterial infections. We have developed F18 FET (Fluoroethyl tyrosine) for imaging brain tumours and adopted the technology in automated synthesis.
Publications
-
Kumar, V., Boddeti, D., Evans, S., Angelides, S. (2012). (68)Ga-Citrate-PET for Diagnostic Imaging of Infection in Rats and for Intra-Abdominal Infection in a Patient. Current Radiopharmaceuticals, 5(1), 71-75
-
Angelides, S., El-Mashaleh, M., Anagnostou, M., Howe, G., Spencer, D., Kumar, V., Manolios, N. (2014). The role of 99mTc-labelled glucosamine (99mTc-ECDG) in the evaluation of rheumatic joint disease: a screening experience. Nuclear Medicine Communications, 35(6), 655-668
-
Vanniasinghe, A., Manolios, N., Schibeci, S., Lakhiani, C., Kamali-Sarvestani, E., Sharma, R., Kumar, V., Moghaddam, M., Ali, M., Bender, V. (2014). Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. Clinical Immunology, 151(1), 43-54
